Brilliant blue G-250
Code | Size | Price |
---|
TAR-T20731-25mg | 25mg | £99.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20731-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20731-50mg | 50mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20731-100mg | 100mg | £128.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20731-200mg | 200mg | £148.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20731-500mg | 500mg | £212.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.
CAS:
6104-58-1
Formula:
C47H48N3NaO7S2
Molecular Weight:
854.02
Pathway:
Neuroscience; Membrane transporter/Ion channel
Purity:
0.98
SMILES:
[Na+].CCOc1ccc(Nc2ccc(cc2)C(=C2C=C/C(/C=C2C)=[N+](CC)Cc2cccc(c2)S([O-])(=O)=O)c2ccc(cc2C)N(CC)Cc2cccc(c2)S([O-])(=O)=O)cc1
Target:
P2X Receptor
References
1. Ferreira LG, Faria RX, Ferreira NC, Soares-Bezerra RJ. Brilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected? Int J Food Sci. 2016;2016:7548498. Epub 2016 Oct 19. Review. PubMed PMID: 27833914; PubMed Central PMCID: PMC5090090.
2. Azuma K, Noda Y, Hirasawa K, Ueta T. BRILLIANT BLUE G-ASSISTED INTERNAL LIMITING MEMBRANE PEELING FOR MACULAR HOLE: A Systematic Review of Literature and Meta-Analysis. Retina. 2016 May;36(5):851-8. doi: 10.1097/IAE.0000000000000968. Review. PubMed PMID: 27115851.
3. Fumagalli M, Lecca D, Abbracchio MP. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology. 2016 May;104:82-93. doi: 10.1016/j.neuropharm.2015.10.005. Epub 2015 Oct 8. Review. PubMed PMID: 26453964.
4. Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology. 2016 May;104:4-17. doi: 10.1016/j.neuropharm.2015.05.031. Epub 2015 Jun 6. Review. PubMed PMID: 26056033.